Chlorodex (LEEFORD)

Quick links

Choose a section

Quick links to important sections

Advertisements

Chlorodex (LEEFORD)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Chlorodex (LEEFORD)

Here are some Quick Facts about this combination medicine:

Property Description
Active Ingredients Chloramphenicol and Dexamethasone
Form Ophthalmic (Eye) or Otic (Ear) drops
Pharmacological Class Antibiotic/Corticosteroid Combination
Common Function Treats infection while reducing inflammation
Prescription Status Prescription-only medicine

Chlorodex (manufactured by LEEFORD Healthcare in India) is a brand-name prescription drug formulated as ophthalmic or otic drops. It is an example of an antibiotic/corticosteroid combination, meaning it provides a dual-action therapeutic approach for specific conditions affecting the eye or ear.

This dual composition is the key feature of Chlorodex. The medication contains the broad-spectrum antibiotic Chloramphenicol, which is clinically recognized for its efficacy in targeting and inhibiting the growth of a wide range of bacteria. This ingredient is recognized for its role in treating bacterial infections in ophthalmic use. This means the medicine includes a strong agent to fight off the germs causing the problem.

The formula also includes Dexamethasone, a potent glucocorticoid steroid. The primary function of this component is to manage the inflammation often caused by the infection or related allergic reactions. Dexamethasone’s strong anti-inflammatory property is recognized for its value in reducing symptoms like swelling, redness, and discomfort. This part of the medicine provides relief by calming the swelling and irritation.

A typical use scenario for a product like Chlorodex is the treatment of bacterial infections in the eye or ear when accompanied by significant inflammation. Because it combines a powerful antibiotic and a strong steroid, Chlorodex is strictly a prescription-only medicine, requiring professional direction to ensure its appropriate and safe use.

Regulatory References

  1. National Institutes of Health (NIH), StatPearls: Chloramphenicol
  2. MedlinePlus: Dexamethasone Ophthalmic
Advertisements

What side effects are possible with Chlorodex (LEEFORD)?

Possible Side Effects and Safety Information

The safety profile for this combination medicine, containing Chloramphenicol and Dexamethasone, addresses risks associated with both the antibiotic and the corticosteroid components, as detailed in official regulatory documents. Adverse reactions are classified by frequency and affected organ system.


Officially Documented Adverse Reactions

The majority of reported reactions are common and localized to the site of application (Eye or Ear disorders), while the most severe risks are classified as rare and related to systemic exposure or prolonged use.

Classification Examples of Officially Listed Adverse Reactions
Common Local irritation, including stinging, burning, itching, transient blurred vision, and redness (conjunctival hyperemia).
Rare/Serious Glaucoma (from increased intraocular pressure, or IOP), posterior subcapsular cataract formation, and irreversible blood dyscrasias like aplastic anemia (associated with Chloramphenicol).

Safety Constraints and Considerations

Official labeling defines specific safety patterns and constraints regarding duration and patient population:

  • Duration-Dependent Risk: The development of increased IOP and cataracts is associated with prolonged use of the Dexamethasone component. Regulatory documents may advise monitoring of IOP if the product is used for ten days or longer.
  • Secondary Infection: Prolonged use of the corticosteroid may suppress the immune response, which can lead to an increased hazard of secondary ocular infections (including fungal) or the overgrowth of non-susceptible organisms.
  • Special Populations: The medicine is not recommended for use during pregnancy or lactation due to the potential for systemic absorption of the active ingredients. Use is contraindicated in individuals with a personal or family history of blood dyscrasias.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The likelihood of acute systemic overdose resulting from the topical application of ophthalmic or otic drops is categorized as minimal in regulatory documents, due to the low concentration of active ingredients.

Overdose scenarios focus on two primary types of excessive exposure:

  • Accidental Ingestion: Should the contents of the vial be accidentally ingested, immediate medical attention is required to initiate measures aimed at delaying and reducing the extent of absorption of the active substances.
  • Chronic Excessive Use: Prolonged administration of the drops in amounts exceeding labeled instructions may lead to systemic corticosteroid effects, including the documented risks of adrenal suppression and Cushing's syndrome.
Documented Severe Outcome Exposure Circumstance
Gray Syndrome (potentially fatal systemic toxicity) High systemic Chloramphenicol exposure, noted as a risk for newborns and infants
Vasomotor Collapse and Death Associated with severe systemic Chloramphenicol toxicity (Gray Syndrome)

If localized overexposure occurs, causing acute eye symptoms such as irritation, pain, swelling, or photophobia, the exposed eye(s) should be irrigated for at least 15 minutes. It is officially stated in regulatory summaries that no specific antidote is known for overdose with this combination product, guiding management toward supportive care.

Advertisements

Therapeutic Uses of Chlorodex (LEEFORD)

What Chlorodex (LEEFORD) Treats: Main Uses and Benefits

The medication is generally used in managing conditions presenting with acute episodes where short-term symptomatic assistance is needed. One of the key components is relevant for antibiotic eye treatment in situations involving certain distressing symptoms.

It is applied in addressing symptom clusters related to heightened physiological activity and managing symptoms that interfere with daily comfort. These are commonly encountered in conditions involving episodic manifestations, heightened symptoms, or acute/unstable symptom patterns.


Easing Symptom Intensity

When symptoms intensify, this medicine offers symptomatic relief that helps with difficult episodes. It is often used when supportive relief is needed to handle symptoms that create noticeable physiological strain. It assists with maintaining functional stability during symptomatic periods.

“This supportive relief is helpful in situations requiring additional symptomatic assistance when symptoms become momentarily overwhelming.”

Supportive Care for Stability

The medication supports general well-being during symptomatic phases. It is applicable within clinical settings marked by increased discomfort and tension, where it supports the patient during difficult episodes by easing distress when symptoms are more noticeable.

Quick Fact: Support for Physiological Strain


Regulatory References

  1. UK Government guidance on Chloramphenicol
Advertisements

Eligibility and Restrictions for Use

Eligibility Rules for Chlorodex

Use of this prescription combination product is determined by strict regulatory rules for its components, Chloramphenicol and Dexamethasone, and is generally permitted for adults and older adults. No dose adjustment is required for geriatric patients.

Absolute Prohibitions (Contraindications)

The medicine is contraindicated and must not be used by patients presenting with:

  • Hypersensitivity to either active substance or any excipients.
  • A personal or family history of blood dyscrasias, including aplastic anaemia, or myelosuppression from prior Chloramphenicol exposure.
  • Viral diseases (e.g., Herpes Simplex Keratitis), fungal diseases (Mycosis), or mycobacterial infections of the eye.
  • Corneal impairment not associated with bacterial infection.

Age and Conditional Restrictions

Population Regulatory Status
Infants (under 28 days) Contraindicated
Children (28 days–2 years) Not Recommended (use only in exceptional cases)
Pregnancy/Lactation Not Recommended (use should be avoided)

Use is also permitted only with caution and close monitoring in patients with conditions such as glaucoma (or ocular hypertension), cataracts, or significantly impaired hepatic or renal function, as detailed in official prescribing information.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for the active ingredients in Chlorodex (Chloramphenicol and Dexamethasone), based strictly on regulatory sources.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Substances/Agents Official Constraint or Outcome
Metabolic/Exposure CYP3A4 Inhibitors (e.g., Ritonavir) May increase systemic exposure of Dexamethasone.
Efficacy Reduction Phenytoin, Rifampicin May reduce the therapeutic efficacy of Dexamethasone.
Pharmacodynamic Anticholinergics (e.g., Atropine) May increase the risk of elevated intraocular pressure.
Contrasting Agents liable to depress bone marrow function Co-administration must be avoided.

Administration-Timing and Population-Specific Constraints

Timing-Based Rule: If using more than one topical ophthalmic medicinal product, the official instruction is that all agents must be administered at least 5 minutes apart.

Population-Specific Caution: For the Chloramphenicol component, cautious administration is required in patients with significantly impaired hepatic and/or renal function, due to the potential for drug accumulation in these populations. The use of other phosphate-containing eye medications with a compromised cornea may also increase the risk of corneal deposits.

Advertisements

Mechanism of Action

Direct Disruption of Microbial Cell Membranes

This domain involves a positively charged molecule that selectively binds to the negatively charged surfaces of various microorganisms, including bacteria and fungi. This strong electrostatic attachment physically disrupts the cell membrane's integrity, leading to the rapid leakage of the microbe's essential internal components. This mechanism contributes directly to the destruction of the microbe and a decrease in the viable microbial population density.


Interference with Essential Protein Manufacturing

A specific component works by entering susceptible bacteria and attaching to the 50S ribosomal subunit, which is critical for assembling proteins. By binding to this subunit, the drug blocks the complex steps needed for the bacteria to synthesize their necessary structural and functional proteins. This interference halts bacterial proliferation and growth, resulting in the disruption of microbial expansion and persistence.


Modulating Key Anti-Inflammatory Pathways

Another component acts by engaging intracellular glucocorticoid receptors as an agonist, initiating a cascade that affects genetic programming. This action suppresses the expression of genes responsible for creating pro-inflammatory mediators, such as certain cytokines and prostaglandins. This targeted modulation dampens the excessive generation of local inflammatory mediators, thereby limiting the resultant physiological responses associated with heightened inflammation.

Advertisements

Dosage and Administration Information

The administration of Chlorodex is characterized for its use as a Topical Ophthalmic and Topical Otic preparation. Dosing follows a structured, time-dependent regimen for acute episodes. For ophthalmic use, the initial schedule often involves 1 to 2 drops every two hours while the patient is awake for the first two days, which then tapers to 1 to 2 drops every four hours for the subsequent five days. The frequency is gradually decreased as clinical signs improve. The total duration of use generally should not exceed 10 days.

The preparation involves specific procedural steps for instillation. The solution or suspension must be shaken well before each use. When applying eye drops, soft contact lenses must be removed prior to instillation. The technique of nasolacrimal occlusion (applying pressure to the inner corner of the eye) for 2 to 3 minutes is used to limit systemic absorption and enhance local activity. If other topical ophthalmic products are used, an interval of at least 5 minutes must be maintained between applications.

Specific parameters apply to different populations for this medication. Use is contraindicated in neonates (infants under 28 days old). For children under two years and infants over 28 days, administration occurs only in exceptional cases. No dose adjustment is required for older adults. The primary structure of use is a fixed-interval tapering course that is strictly short-term.

Advertisements

Recent Clinical Evidence

This section provides a patient-friendly overview of the official research structure—including the types of studies, populations evaluated, and outcomes tracked—used by regulators when assessing the authorization of Chlorodex (Chloramphenicol/Dexamethasone) drops.


Evidence for Use in Acute Ocular Inflammation

Research was studied for conditions involving inflammation and bacterial infection in the front part of the eye. Studies included Randomized Controlled Trials (RCTs) and Systematic Reviews that evaluate topical combinations. These research efforts explored outcomes related to physical discomfort and changes in visual signs, such as redness and discharge. Researchers also monitored laboratory-based measures to track changes in microbiological status. The evidence base includes long-standing data related to the use of both components. However, there is limited head-to-head research comparing this exact combination against all other available newer options.


Evidence for Use in Acute Otitis Externa

For conditions associated with acute or disruptive episodes in the ear canal, research was evaluated in settings that included Systematic Reviews and Meta-analyses of various topical drops. Studies monitored outcomes capturing phases of heightened symptom activity, such as the rate of Clinical Cure and changes in inflammatory signs. The research base related to this specific combination is less extensive, and there is limited information for specific scenarios. Specific large-scale, high-quality RCTs focusing exclusively on the Chloramphenicol/Dexamethasone combination itself are noted as being scarce.


Long-Term Studies and Follow-Up Data

Research primarily explores short-term symptom changes over defined time intervals. The treatment durations were limited, generally lasting 7 to 10 days for the acute infection. Consequently, research does not determine whether an individual will respond similarly over extended periods. Long-term effects are not fully established and comparative evidence is lacking regarding the long-term durability of the response.


Evidence in Specific Patient Groups

Studies have included older adults in general research, and regulatory reviews indicate the research data for adults is better established than that available for younger patients. For infants and very young children (under two years of age), data are currently limited and considered insufficient compared to adult data. Subgroup findings are uncertain, as the results apply only to the populations studied.


Areas of Research Uncertainty and Study Limitations

The evidence landscape primarily describes patterns observed in studies regarding short-term changes in acute infections. However, several limitations remain. The follow-up durations were limited in most acute studies, meaning long-term effects are not fully established. Additionally, comparative evidence is lacking in some areas. Research does not determine whether an individual will respond similarly, and evidence quality varies across studies.

Key Studies & References

  1. MedlinePlus: Dexamethasone Ophthalmic
  2. UK Government guidance on Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years (Drug Safety Update)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Chlorodex (LEEFORD) (FAQ)


Q: Are there any common side effects people report when taking Chlorodex (LEEFORD)?

According to official product information, the most common side effects reported with these topical drops are localized reactions at the application site. These often include temporary sensations like stinging, burning, itching, or a visible redness of the conjunctiva. These common effects are generally transient and are described in the product information as temporary.


Q: Is it generally safe for elderly patients to use Chlorodex (LEEFORD)?

Regulatory guidance for Chlorodex indicates that this medicine is generally permitted for use in older adults. Official product information confirms that no dose adjustment is typically required for geriatric patients compared to younger adults.


Q: What level of evidence supports the effectiveness of Chlorodex (LEEFORD)?

The evidence supporting the use of Chlorodex is based on the long history of clinical use for its active components and the studies submitted for authorization. Research has included established methods like Randomized Controlled Trials (RCTs) and Systematic Reviews evaluating both the steroid and antibiotic components for their intended uses.


Q: What if I drink alcohol while taking Chlorodex (LEEFORD)?

Official regulatory documents for the topical drops do not list a direct interaction with alcohol. However, official information often suggests limiting alcohol intake while dealing with any acute infection.


Q: Does Chlorodex (LEEFORD) interact with common over-the-counter pain relievers?

Official interaction lists for this topical product do not specifically highlight common over-the-counter (OTC) pain relievers. However, since the medicine contains a potent steroid, official product information suggests careful consideration if used alongside certain OTC medications like NSAIDs (e.g., ibuprofen). This suggestion is based on potential risks associated with steroid absorption, though systemic absorption is limited.


Q: What is the average duration of action for Chlorodex (LEEFORD)?

Chlorodex is primarily intended for local activity in the eye or ear. When considering how the drug clears the body, the half-life of the Chloramphenicol component is typically between 1.5 to 3.5 hours, and the Dexamethasone component is around 4 hours in adults with normal function. The half-life relates to the time required to clear the drug from the body.


Q: How quickly should I expect Chlorodex (LEEFORD) to start working?

The anti-inflammatory action of the Dexamethasone component often provides relief from swelling and redness fairly quickly. Official documents state that if a patient does not show a relevant clinical response after approximately three days of use, the treatment should be re-evaluated.


Q: Is Chlorodex (LEEFORD) a brand name or a generic drug?

Chlorodex is a specific brand-name drug. The active ingredients contained within it, Chloramphenicol and Dexamethasone, are widely available as generic medicines in various formulations globally.


Q: Does Chlorodex (LEEFORD) have a high risk of drug interactions?

Because Chlorodex is applied topically to the eye or ear, the risk of serious, systemic drug interactions is generally considered low compared to oral medications. However, official documents list interactions that must be avoided, such as with certain CYP3A4 inhibitors and medicines known to depress bone marrow function.


Q: Can Chlorodex (LEEFORD) be taken by people with kidney concerns?

Regulatory documents indicate that cautious administration is required for patients who have significantly impaired renal (kidney) function. This caution is necessary because there is a potential risk for the drug's components to accumulate in the body under these conditions.


Q: Does taking Chlorodex (LEEFORD) affect sleep patterns?

Systemic absorption of the Dexamethasone component, while limited with topical drops, is known to potentially cause side effects such as difficulty sleeping or insomnia. This is a known potential effect related to the steroid component, and product information often describes it.


Q: Is Chlorodex (LEEFORD) considered a controlled substance?

No, Chlorodex is not classified as a controlled substance by regulatory bodies in the United States or many other countries. The active ingredients, Chloramphenicol and Dexamethasone, do not fall under the schedule classification for controlled substances.


Q: Is it normal to feel nauseous after starting Chlorodex (LEEFORD)?

Nausea is not documented as a common or frequent adverse reaction for the topical drops. However, it is noted that the systemic use of the Dexamethasone component can potentially be associated with general stomach upset.


Q: Can Chlorodex (LEEFORD) affect the results of common lab tests?

Official information indicates that the Dexamethasone component can interfere with certain endocrine lab tests. Specifically, it is known to affect tests like the dexamethasone suppression test, which is a method used to measure cortisol levels.


Q: Why is Chlorodex (LEEFORD) contraindicated for people with certain heart conditions?

While not listed as an absolute contraindication for the topical form, the corticosteroid component is used with caution in patients with certain heart conditions. This is because systemic absorption could potentially lead to fluid retention or blood pressure elevation.


Q: How does the mechanism of action of Chlorodex (LEEFORD) relate to its intended effect?

The mechanism of action is dual: the Chloramphenicol component targets the infection by inhibiting the protein synthesis necessary for bacterial growth. Simultaneously, the Dexamethasone component acts to suppress the body's creation of pro-inflammatory mediators, which rapidly reduces the associated symptoms like swelling and redness.


Q: Is Chlorodex (LEEFORD) known to cause changes in mood or behavior?

Systemic corticosteroids are known to potentially cause mood and behavior changes, which can include feelings of anxiety, depression, or euphoria. While topical use generally minimizes systemic absorption, official documents note this as a potential effect related to the Dexamethasone component.


Q: What is the role of the inactive ingredients in Chlorodex (LEEFORD)?

The inactive ingredients, also known as excipients, are non-medicinal substances in the formulation. Their role is to help maintain the drug's overall stability, ensure its proper shelf-life, and aid in the correct application to the eye or ear. Common examples of these are preservatives or stabilizing agents.


Q: Is Chlorodex (LEEFORD) safe to use during pregnancy according to official sources?

Official regulatory sources indicate that the use of this medicine is not recommended during pregnancy or lactation. The medication is generally avoided in these populations unless a healthcare professional determines its use to be absolutely essential based on the specific condition.


Q: Are there any documented cases of serious side effects with Chlorodex (LEEFORD)?

Yes, official documents list several serious adverse reactions that have been documented. These include the rare risk of irreversible blood disorders like aplastic anemia associated with the Chloramphenicol component. Prolonged use of the Dexamethasone component is also associated with the risk of developing glaucoma or cataracts.


Q: How is Chlorodex (LEEFORD) eliminated from the body?

When absorbed, the Chloramphenicol component is primarily processed (metabolized) by the liver before being eliminated from the body, mostly through the kidneys via urine. The Dexamethasone component is also metabolized mainly by the liver, involving specific enzymes.


Q: Does Chlorodex (LEEFORD) carry a Black Box Warning in the US?

Yes, the U.S. Food and Drug Administration (FDA) requires a Boxed Warning for topical products containing the active ingredient Chloramphenicol. This warning highlights the potential, although rare, risk of developing fatal blood disorders, such as aplastic anemia.


Q: Is Chlorodex (LEEFORD) known to cause weight gain or loss?

Systemic use of the Dexamethasone component is commonly associated with appetite changes and weight gain. While this risk is significantly lower with the topical drops, the potential for this type of metabolic effect is noted in the information for the steroid component.


Q: Is it possible for Chlorodex (LEEFORD) to lose effectiveness over time?

Official warnings indicate that prolonged use of the medicine may increase the risk of the overgrowth of non-susceptible organisms or fungi. This situation would result in the infection not responding to the treatment, making the medicine appear to have lost its effectiveness.


Q: Do any official documents discuss Chlorodex (LEEFORD) use in pediatric populations?

Yes, regulatory documents specifically discuss the use of Chlorodex in younger patients. It is contraindicated in neonates (infants under 28 days old) and official guidance advises that its use in children between 28 days and two years of age should be reserved only for exceptional cases.


Q: Is Chlorodex (LEEFORD) considered a first-line treatment for its primary indication?

Regulatory bodies often do not consider Chloramphenicol to be a first-line treatment for all infections. Official guidance describes its use as often reserved for serious infections where alternatives are deemed unsuitable or ineffective.


Q: What is the half-life of Chlorodex (LEEFORD)?

The half-life is the time it takes for half of the dose to be cleared from the bloodstream. For the Chloramphenicol component, the half-life is typically between 1.5 and 3.5 hours, and for the Dexamethasone component, it is around 4 hours in adults with normal organ function.


Q: How can I get a patient information leaflet for Chlorodex (LEEFORD)?

The Patient Information Leaflet (PIL) comes inside the medication package. You can also typically find official copies by searching the electronic databases of national regulatory agencies, such as the U.S. DailyMed or the websites of the European Medicines Agency (EMA).


Q: Are there specific food items or beverages that should be avoided while using Chlorodex (LEEFORD)?

Official drug information sources do not list any specific food items or beverages that have documented interactions with the topical drops. Due to the method of application, the risk of food interactions with this form of the medicine is generally considered negligible.


Q: How long can a person safely stay on Chlorodex (LEEFORD)?

Official instructions for acute treatment indicate that the total duration of use generally does not exceed 10 days. Prolonged use of the Dexamethasone component is associated with serious duration-dependent risks, including the potential for increased pressure inside the eye (glaucoma) and cataract formation.

Advertisements

How should Chlorodex (LEEFORD) be stored and disposed of?

How to Store and Dispose of Chlorodex (LEEFORD)?

Official regulatory documentation defines precise requirements for storing and disposing of this medication to maintain its stability and effectiveness.

Official Storage Conditions

Storage Requirement Official Classification
Temperature Store at room temperature, typically 20 C to 25 C. Do not freeze.
Protection Keep in the original container, tightly closed, and protect from light.
Handling Keep out of reach of children. Do not refrigerate unless specifically labeled.
In-Use Stability Discard the container and any remaining medicine 28 days after first opening, as directed by official labeling.

Disposal Instructions

Dispose of expired or unused medication according to local requirements for medical products. Do not flush the product down a toilet or pour it into a drain. Disposal must follow strict local environmental and medical waste regulations to ensure proper control and prevent contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Chlorodex (LEEFORD) found in:

A-Z Index: